Perry Moss, appointed CEO last month, said in an interview that he would bring a new “process-oriented” perspective to the ...
Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback